50e per dosis would be a great price, until you find out someone else already got much better price for the same thing from the same company. Hint: US pays ~16 EUR, and US is the one that usually overpays healthcare.
I am still surprised most people around the world, inclusive of those in purchasing and procurement, fail to understand the time and value proposition in the equation. Entrepreneur or Business man tends to be far better at it.
In Germany that opportunity cost after 3 months of lockdown is huge.